NEUROENDOCRINE TUMOUR

This adverse event was reported 1417 times

These drugs are most commonly taken by patients reporting NEUROENDOCRINE TUMOUR:

# Drug Count
0 OCTREOTIDE ACETATE 412
1 EVEROLIMUS 227
2 LUTETIUM LU 177 DOTATATE 103
3 EVEROLIMUS TABLETS 63
4 ADALIMUMAB 56
5 METFORMIN 55
6 METHOTREXATE SODIUM 55
7 OMEPRAZOLE MAGNESIUM 55
8 AMLODIPINE 50
9 METHOTREXATE 50
See all common drugs associated with NEUROENDOCRINE TUMOUR

NEUROENDOCRINE TUMOUR is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 STREPTOZOCIN 6 0.0261
1 TELMISARTAN AND AMLODIPINE 2 0.0200
2 LUTETIUM LU 177 DOTATATE 103 0.0177
3 INDIUM IN -111 PENTETREOTIDE 2 0.0156
4 OCTREOTIDE ACETATE 412 0.0134
5 CEFOTETAN 1 0.0075
6 EVEROLIMUS 227 0.0046
7 EVEROLIMUS TABLETS 63 0.0037
8 1169 HYDROGEN PEROXIDE SPRAY 1 0.0032
9 LANREOTIDE ACETATE 19 0.0024
See all drugs enriched for association with NEUROENDOCRINE TUMOUR